Masimo IP Verdict A Timely Warning For All Device Inventors, Says Counsel
Masimo Corp. has spent much time and effort over the last decade and a half addressing patent and IP issues surrounding its pulse oximetry technology – and it’s not over yet: an ongoing case with Philips and a future case with Mindray Medical will keep the company busy for some time to come. But for Masimo’s legal counsel, these cases underline the vital need for appropriate protection of inventions – and not just for the company’s benefit.
You may also be interested in...
The much-anticipated return to a “normal” NHS service delivery could yet be dashed by a resurgence of the virus.
Hospital administrators and clinicians in Germany seek enhanced digitization of clinical procedures, but the budgets have not always been available. A new “future hospitals investment” program, now made into a draft law, should reserve funds for robotics and digital health care.
In this Device Week, Ashley Yeo asks PB Consulting managing director Dan Jones about the adjustments needed by UK medtechs as they face a confluence of change brought about by Brexit, COVID-19 and NHS reform, at a time when the MHRA is also coming under increased scrutiny.